Found 84 with Last Name = 'kazantsev' and Initial = 'ag' TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 750nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.70E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of SIRT2 (unknown origin) by Flour-de-Lys fluorescent biochemical assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 2.90E+3nMAssay Description:Inhibition of SIRT2 (unknown origin) by Flour-de-Lys fluorescent biochemical assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 3.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of human recombinant SIRT2 using fluorescent peptide substrate by fluorescent assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 3.80E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 4.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 4.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 4.70E+3nMAssay Description:Inhibition of SIRT2 (unknown origin) by Flour-de-Lys fluorescent biochemical assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 4.90E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-3, mitochondrial(Homo sapiens (Human))
Harvard Medical School
Curated by ChEMBL
Harvard Medical School
Curated by ChEMBL
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of human recombinant SIRT3 using fluorescent peptide substrate by fluorescent assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 5.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 5.50E+3nMAssay Description:Inhibition of human recombinant SIRT2 using fluorescent peptide substrate by fluorescent assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of human recombinant SIRT2 using fluorescent peptide substrate by fluorescent assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.10E+3nMAssay Description:Inhibition of SIRT2 (unknown origin) by Flour-de-Lys fluorescent biochemical assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.10E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.10E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.30E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.60E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.70E+3nMAssay Description:Inhibition of SIRT2 (unknown origin) by Flour-de-Lys fluorescent biochemical assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.80E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.90E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 7.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 7.10E+3nMAssay Description:Inhibition of SIRT2 (unknown origin) by Flour-de-Lys fluorescent biochemical assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 7.30E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 7.50E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 7.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 7.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 8.40E+3nMAssay Description:Inhibition of SIRT2 (unknown origin) by Flour-de-Lys fluorescent biochemical assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 9.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 9.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 9.10E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 9.40E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 9.50E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 9.50E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 9.60E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 9.80E+3nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human recombinant SIRT2 using fluorescent peptide substrate by fluorescent assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.02E+4nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.08E+4nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.15E+4nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.20E+4nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.25E+4nMAssay Description:Inhibition of SIRT-2 (unknown origin)More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.25E+4nMAssay Description:Inhibition of SIRT2 (unknown origin) by Flour-de-Lys fluorescent biochemical assayMore data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.25E+4nMAssay Description:Inhibition of SIRT2 (unknown origin)More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.32E+4nMAssay Description:Inhibition of SIRT-2 (unknown origin) by fluorescence assayMore data for this Ligand-Target Pair
